PARAMETERS OF ARACHYDONIC ACID CYCLE METABOLISM IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION ON THE BACKGROUND OF COMPLEX THERAPY OF OMEGA-3 POLYUNSATURATED FATTY ACIDS

The aim of the study was to evaluate the effect of omega-3 polyunsaturated fatty acids on the main metabolic rates of the arachydonic acid cycle in patients with acute myocardial infarction in the context of traditional complex therapy. Materials and methods of research. We conducted an open, random...

Full description

Bibliographic Details
Main Authors: V. P. Mikhin, A. I. Shveinov, M. A. Chernyatina, A. V. Kharchenko, G. V. Panchenko, N. I. Gromnatsky
Format: Article
Language:Russian
Published: SINAPS LLC 2017-12-01
Series:Архивъ внутренней медицины
Subjects:
Online Access:https://www.medarhive.ru/jour/article/view/720
_version_ 1797883790038663168
author V. P. Mikhin
A. I. Shveinov
M. A. Chernyatina
A. V. Kharchenko
G. V. Panchenko
N. I. Gromnatsky
author_facet V. P. Mikhin
A. I. Shveinov
M. A. Chernyatina
A. V. Kharchenko
G. V. Panchenko
N. I. Gromnatsky
author_sort V. P. Mikhin
collection DOAJ
description The aim of the study was to evaluate the effect of omega-3 polyunsaturated fatty acids on the main metabolic rates of the arachydonic acid cycle in patients with acute myocardial infarction in the context of traditional complex therapy. Materials and methods of research. We conducted an open, randomized study of two groups of patients (n=59) with acute myocardial infarction (MI), which did not undergo angioplastic and thrombolysis: in the main group (n=26) traditional complex therapy (including double antiaggregant therapy) from the first day supplemented with Omega-3 triglycerides [EPA/DGA — 1.2/1-90%] 1g. per day. In the control group (n=33) only complex therapy was performed. The main components of the arachydonic acid cycle — thromboxane B2 (TxB2) and prostaglandin I2 (PgI2), as well as their analogues, thromboxane B3 (TxB3) and prostaglandin I3 (PgI3), resulting from the replacement of arachidonic acid by omega-3 PUFAs, were evaluated for all patients on the 1st, 7th, 14th days after the onset of MI in the blood plasma. Results of the study. On day 14, an increase in the level of prostaglandin I3 in the Omega-3 triglycerides [EPA/DGA — 1.2/1-90%] group was observed in 10 times, the level of thromboxane B3 was increased in 15.9 times, in the absence of significant differences between the groups in the thromboxane B2 and prostaglandin I2 level. A decrease in the ratios of PgI2 / PgI3 and TxB2 / TxB3 in the main group also was noted. Conclusion. Given the lower functional activity of thromboxane B3 and the decrease in the ratio of TxB2 / TxB3, against the background of Omega-3 triglycerides [EPA/DGA — 1.2/1-90%] therapy, one can judge the presence of an independent antiaggregant effect of omega-3-polyunsaturated fatty acids as a result of their use in patients with MI.
first_indexed 2024-04-10T03:56:17Z
format Article
id doaj.art-98bd4e33fe7c4054ac182049ce4524d6
institution Directory Open Access Journal
issn 2226-6704
2411-6564
language Russian
last_indexed 2024-04-10T03:56:17Z
publishDate 2017-12-01
publisher SINAPS LLC
record_format Article
series Архивъ внутренней медицины
spelling doaj.art-98bd4e33fe7c4054ac182049ce4524d62023-03-13T07:12:08ZrusSINAPS LLCАрхивъ внутренней медицины2226-67042411-65642017-12-017645045410.20514/2226-6704-2017-7-6-450-454644PARAMETERS OF ARACHYDONIC ACID CYCLE METABOLISM IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION ON THE BACKGROUND OF COMPLEX THERAPY OF OMEGA-3 POLYUNSATURATED FATTY ACIDSV. P. Mikhin0A. I. Shveinov1M. A. Chernyatina2A. V. Kharchenko3G. V. Panchenko4N. I. Gromnatsky5ФГБОУ ВО «Курский государственный медицинский университет» Минздрава РФ.ОБУЗ «Курская городская клиническая больница скорой медицинской помощи».ФГБОУ ВО «Курский государственный медицинский университет» Минздрава РФ.ФГБОУ ВО «Курский государственный медицинский университет» Минздрава РФ.ОБУЗ «Курская городская клиническая больница скорой медицинской помощи».ФГБОУ ВО «Курский государственный медицинский университет» Минздрава РФ.The aim of the study was to evaluate the effect of omega-3 polyunsaturated fatty acids on the main metabolic rates of the arachydonic acid cycle in patients with acute myocardial infarction in the context of traditional complex therapy. Materials and methods of research. We conducted an open, randomized study of two groups of patients (n=59) with acute myocardial infarction (MI), which did not undergo angioplastic and thrombolysis: in the main group (n=26) traditional complex therapy (including double antiaggregant therapy) from the first day supplemented with Omega-3 triglycerides [EPA/DGA — 1.2/1-90%] 1g. per day. In the control group (n=33) only complex therapy was performed. The main components of the arachydonic acid cycle — thromboxane B2 (TxB2) and prostaglandin I2 (PgI2), as well as their analogues, thromboxane B3 (TxB3) and prostaglandin I3 (PgI3), resulting from the replacement of arachidonic acid by omega-3 PUFAs, were evaluated for all patients on the 1st, 7th, 14th days after the onset of MI in the blood plasma. Results of the study. On day 14, an increase in the level of prostaglandin I3 in the Omega-3 triglycerides [EPA/DGA — 1.2/1-90%] group was observed in 10 times, the level of thromboxane B3 was increased in 15.9 times, in the absence of significant differences between the groups in the thromboxane B2 and prostaglandin I2 level. A decrease in the ratios of PgI2 / PgI3 and TxB2 / TxB3 in the main group also was noted. Conclusion. Given the lower functional activity of thromboxane B3 and the decrease in the ratio of TxB2 / TxB3, against the background of Omega-3 triglycerides [EPA/DGA — 1.2/1-90%] therapy, one can judge the presence of an independent antiaggregant effect of omega-3-polyunsaturated fatty acids as a result of their use in patients with MI.https://www.medarhive.ru/jour/article/view/720омега-3 полиненасыщенные жирные кислотытромбоксанпростациклинострый инфаркт миокардацикл арахидоновой кислоты
spellingShingle V. P. Mikhin
A. I. Shveinov
M. A. Chernyatina
A. V. Kharchenko
G. V. Panchenko
N. I. Gromnatsky
PARAMETERS OF ARACHYDONIC ACID CYCLE METABOLISM IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION ON THE BACKGROUND OF COMPLEX THERAPY OF OMEGA-3 POLYUNSATURATED FATTY ACIDS
Архивъ внутренней медицины
омега-3 полиненасыщенные жирные кислоты
тромбоксан
простациклин
острый инфаркт миокарда
цикл арахидоновой кислоты
title PARAMETERS OF ARACHYDONIC ACID CYCLE METABOLISM IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION ON THE BACKGROUND OF COMPLEX THERAPY OF OMEGA-3 POLYUNSATURATED FATTY ACIDS
title_full PARAMETERS OF ARACHYDONIC ACID CYCLE METABOLISM IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION ON THE BACKGROUND OF COMPLEX THERAPY OF OMEGA-3 POLYUNSATURATED FATTY ACIDS
title_fullStr PARAMETERS OF ARACHYDONIC ACID CYCLE METABOLISM IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION ON THE BACKGROUND OF COMPLEX THERAPY OF OMEGA-3 POLYUNSATURATED FATTY ACIDS
title_full_unstemmed PARAMETERS OF ARACHYDONIC ACID CYCLE METABOLISM IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION ON THE BACKGROUND OF COMPLEX THERAPY OF OMEGA-3 POLYUNSATURATED FATTY ACIDS
title_short PARAMETERS OF ARACHYDONIC ACID CYCLE METABOLISM IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION ON THE BACKGROUND OF COMPLEX THERAPY OF OMEGA-3 POLYUNSATURATED FATTY ACIDS
title_sort parameters of arachydonic acid cycle metabolism in patients with acute myocardial infarction on the background of complex therapy of omega 3 polyunsaturated fatty acids
topic омега-3 полиненасыщенные жирные кислоты
тромбоксан
простациклин
острый инфаркт миокарда
цикл арахидоновой кислоты
url https://www.medarhive.ru/jour/article/view/720
work_keys_str_mv AT vpmikhin parametersofarachydonicacidcyclemetabolisminpatientswithacutemyocardialinfarctiononthebackgroundofcomplextherapyofomega3polyunsaturatedfattyacids
AT aishveinov parametersofarachydonicacidcyclemetabolisminpatientswithacutemyocardialinfarctiononthebackgroundofcomplextherapyofomega3polyunsaturatedfattyacids
AT machernyatina parametersofarachydonicacidcyclemetabolisminpatientswithacutemyocardialinfarctiononthebackgroundofcomplextherapyofomega3polyunsaturatedfattyacids
AT avkharchenko parametersofarachydonicacidcyclemetabolisminpatientswithacutemyocardialinfarctiononthebackgroundofcomplextherapyofomega3polyunsaturatedfattyacids
AT gvpanchenko parametersofarachydonicacidcyclemetabolisminpatientswithacutemyocardialinfarctiononthebackgroundofcomplextherapyofomega3polyunsaturatedfattyacids
AT nigromnatsky parametersofarachydonicacidcyclemetabolisminpatientswithacutemyocardialinfarctiononthebackgroundofcomplextherapyofomega3polyunsaturatedfattyacids